NYSE:STE STERIS (STE) Stock Forecast, Price & News $199.43 -1.01 (-0.50%) (As of 01:56 PM ET) Add Compare Share Share Today's Range$199.33▼$201.4350-Day Range$181.42▼$210.8552-Week Range$159.21▼$234.26Volume103,140 shsAverage Volume494,644 shsMarket Capitalization$19.80 billionP/E Ratio186.38Dividend Yield0.94%Price Target$226.40 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability STERIS MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside11.6% Upside$223.00 Price TargetShort InterestHealthy2.11% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-2.00Upright™ Environmental ScoreNews Sentiment0.24Based on 14 Articles This WeekInsider TradingSelling Shares$439,207 Sold Last QuarterProj. Earnings Growth10.64%From $8.65 to $9.57 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.34 out of 5 starsMedical Sector267th out of 1,009 stocksSurgical Appliances & Supplies Industry10th out of 20 stocks 2.3 Analyst's Opinion Consensus RatingSTERIS has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $223.00, STERIS has a forecasted upside of 11.6% from its current price of $199.85.Amount of Analyst CoverageSTERIS has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.11% of the float of STERIS has been sold short.Short Interest Ratio / Days to CoverSTERIS has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in STERIS has recently decreased by 4.13%, indicating that investor sentiment is improving. Previous Next 2.5 Dividend Strength Dividend YieldSTERIS has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthSTERIS has been increasing its dividend for 17 years.Dividend CoverageThe dividend payout ratio of STERIS is 175.70%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, STERIS will have a dividend payout ratio of 19.64% next year. This indicates that STERIS will be able to sustain or increase its dividend. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSTERIS has received a 50.90% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Antiseptic hand rubs", "Medical endoscopes", and "Surgical masks" products. See details.Environmental SustainabilityThe Environmental Impact score for STERIS is -2.00. Previous Next 2.4 News and Social Media Coverage News SentimentSTERIS has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for STERIS this week, compared to 5 articles on an average week.Search Interest13 people have searched for STE on MarketBeat in the last 30 days. MarketBeat FollowsOnly 3 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $439,207.00 in company stock.Percentage Held by InsidersOnly 0.95% of the stock of STERIS is held by insiders.Percentage Held by Institutions92.35% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for STERIS are expected to grow by 10.64% in the coming year, from $8.65 to $9.57 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STERIS is 186.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 127.10.Price to Earnings Ratio vs. SectorThe P/E ratio of STERIS is 186.78, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 90.44.Price to Earnings Growth RatioSTERIS has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSTERIS has a P/B Ratio of 3.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About STERIS (NYSE:STE) StockSTERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Mentor, OH.Read More Receive STE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter. Email Address STE Stock News HeadlinesMay 30, 2023 | markets.businessinsider.comAnalyst Ratings for SterisMay 30, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Coverage Initiated at Morgan StanleyMay 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 28, 2023 | americanbankingnews.comQ1 2024 EPS Estimates for STERIS plc (NYSE:STE) Lowered by AnalystMay 24, 2023 | wsj.comSteris PLCMay 23, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Axsome Therapeutics (AXSM) and Steris (STE)May 20, 2023 | msn.comWidely viewed video alleges safety concerns at UAB hospitalMay 18, 2023 | americanbankingnews.comMohsen Sohi Sells 2,069 Shares of STERIS plc (NYSE:STE) StockMay 30, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 16, 2023 | marketwatch.comIonizing Radiation Sterilization Market Expected Growth, Demand and Trends for 2030 | Astell, Getinge, SterisMay 16, 2023 | americanbankingnews.comKeyCorp Weighs in on STERIS plc's Q2 2024 Earnings (NYSE:STE)May 15, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Issues FY 2024 Earnings GuidanceMay 15, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Price Target Raised to $200.00 at Piper SandlerMay 13, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Price Target Increased to $235.00 by Analysts at KeyCorpMay 13, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Shares Gap Up Following Strong EarningsMay 12, 2023 | msn.comSteris: FCF Generation, No Supply Chain Risks, And UndervaluedMay 12, 2023 | msn.comSteris Delivered Strong Q4 Performance, But Analyst Call FY24 Outlook MixedMay 12, 2023 | msn.comKeybanc Maintains Steris (STE) Overweight RecommendationMay 11, 2023 | msn.comRecap: Steris Q4 EarningsMay 11, 2023 | sfgate.comSteris: Fiscal Q4 Earnings SnapshotMay 11, 2023 | markets.businessinsider.comSTERIS plc Q1 Profit Increases, beats estimatesMay 11, 2023 | benzinga.comSTERIS shares are trading higher after the company reported better-than-expected Q4 results.May 11, 2023 | finance.yahoo.comWhy Shares of Steris Are Up ThursdayMay 11, 2023 | finanznachrichten.deSTERIS plc: STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full YearMay 10, 2023 | marketwatch.comSteris PLC stock outperforms market on strong trading dayMay 10, 2023 | finance.yahoo.comSTERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full YearMay 10, 2023 | finance.yahoo.comSteris (STE) Beats Q4 Earnings and Revenue EstimatesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter. Email Address STE Company Calendar Ex-Dividend for 3/23 Dividend2/23/2023Dividend Payable3/23/2023Last Earnings5/10/2023Today5/30/2023Ex-Dividend for 6/28 Dividend6/13/2023Dividend Payable6/28/2023Next Earnings (Estimated)8/01/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:STE CUSIP85915210 CIK1624899 Webwww.steris.com Phone(440) 354-2600Fax440-639-4457Employees16,422Year Founded1987Price Target and Rating Average Stock Price Forecast$223.00 High Stock Price Forecast$240.00 Low Stock Price Forecast$200.00 Forecasted Upside/Downside+13.0%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$1.07 Trailing P/E Ratio187.33 Forward P/E Ratio23.17 P/E Growth2.11Net Income$107.03 million Net Margins2.16% Pretax Margin2.13% Return on Equity13.50% Return on Assets7.60% Debt Debt-to-Equity Ratio0.50 Current Ratio2.33 Quick Ratio1.53 Sales & Book Value Annual Sales$4.96 billion Price / Sales4.01 Cash Flow$13.22 per share Price / Cash Flow15.16 Book Value$61.31 per share Price / Book3.27Miscellaneous Outstanding Shares99,280,000Free Float98,341,000Market Cap$19.90 billion OptionableOptionable Beta0.85 Social Links Key ExecutivesDaniel A. CarestioPresident, Chief Executive Officer & DirectorMichael Joseph TokichChief Financial Officer & Senior Vice PresidentKathleen Lynn BardwellChief Compliance Officer & Senior Vice PresidentJohn Adam ZangerleSecretary, Senior Vice President & General CounselRenato G. TamaroTreasurer & Vice PresidentKey CompetitorsEdwards LifesciencesNYSE:EWAlign TechnologyNASDAQ:ALGNSmith & NephewNYSE:SNNZimmer BiometNYSE:ZBHHologicNASDAQ:HOLXView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 1,815 shares on 5/26/2023Ownership: 0.015%Toroso Investments LLCBought 170 shares on 5/23/2023Ownership: 0.003%Ameriprise Financial Inc.Sold 41,208 shares on 5/22/2023Ownership: 0.294%American TrustSold 160 shares on 5/22/2023Ownership: 0.002%Courier Capital LLCBought 478 shares on 5/18/2023Ownership: 0.002%View All Insider TransactionsView All Institutional Transactions STE Stock - Frequently Asked Questions Should I buy or sell STERIS stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STE shares. View STE analyst ratings or view top-rated stocks. What is STERIS's stock price forecast for 2023? 6 Wall Street analysts have issued 12 month target prices for STERIS's stock. Their STE share price forecasts range from $200.00 to $240.00. On average, they anticipate the company's share price to reach $223.00 in the next year. This suggests a possible upside of 11.2% from the stock's current price. View analysts price targets for STE or view top-rated stocks among Wall Street analysts. How have STE shares performed in 2023? STERIS's stock was trading at $184.69 at the start of the year. Since then, STE stock has increased by 8.6% and is now trading at $200.56. View the best growth stocks for 2023 here. When is STERIS's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023. View our STE earnings forecast. How were STERIS's earnings last quarter? STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, May, 10th. The medical equipment provider reported $2.30 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.15. The medical equipment provider had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.27 billion. STERIS had a net margin of 2.16% and a trailing twelve-month return on equity of 13.50%. During the same quarter in the previous year, the business earned $2.04 earnings per share. Read the conference call transcript. How often does STERIS pay dividends? What is the dividend yield for STERIS? STERIS announced a quarterly dividend on Wednesday, May 3rd. Stockholders of record on Wednesday, June 14th will be paid a dividend of $0.47 per share on Wednesday, June 28th. This represents a $1.88 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Tuesday, June 13th. Read our dividend analysis for STE. What ETFs hold STERIS's stock? ETFs with the largest weight of STERIS (NYSE:STE) stock in their portfolio include VanEck Environmental Services ETF (EVX), VictoryShares THB Mid Cap ESG ETF (MDCP), First Trust Indxx Medical Devices ETF (MDEV), Nuveen ESG Mid-Cap Value ETF (NUMV), iShares U.S. Medical Devices ETF (IHI), Invesco S&P 500 Equal Weight Health Care ETF (RYH), BlackRock Future Health ETF (BMED) and SPDR S&P Health Care Equipment ETF (XHE). Is STERIS a good dividend stock? STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.94%. The company has been increasing its dividend for 17 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 175.70%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, STE will have a dividend payout ratio of 19.64% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for STE. What guidance has STERIS issued on next quarter's earnings? STERIS updated its FY 2024 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of $8.55-$8.75 for the period, compared to the consensus EPS estimate of $8.75. The company issued revenue guidance of $5.30 billion-$5.35 billion, compared to the consensus revenue estimate of $5.14 billion. What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO? 196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees. What other stocks do shareholders of STERIS own? Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT). What is STERIS's stock symbol? STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE." Who are STERIS's major shareholders? STERIS's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.74%), WCM Investment Management LLC (5.50%), State Street Corp (4.13%), Price T Rowe Associates Inc. MD (2.30%), Geode Capital Management LLC (2.07%) and Pictet Asset Management SA (1.46%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden and Walter M Rosebrough Jr. View institutional ownership trends. How do I buy shares of STERIS? Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is STERIS's stock price today? One share of STE stock can currently be purchased for approximately $200.56. How much money does STERIS make? STERIS (NYSE:STE) has a market capitalization of $19.91 billion and generates $4.96 billion in revenue each year. The medical equipment provider earns $107.03 million in net income (profit) each year or $1.07 on an earnings per share basis. How many employees does STERIS have? The company employs 16,422 workers across the globe. How can I contact STERIS? STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (440) 354-2600, via email at julie_winter@steris.com, or via fax at 440-639-4457. This page (NYSE:STE) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.